MedTrace Logo

Plantar Fasciosis Treatment Using Coblation

NCT00189592 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2015-08-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of Coblation-based fasciotomy for relieving pain associated with recurring plantar fasciosis and, secondarily, to determine whether there may be additional potential benefits stemming from its use.

Conditions

  • Plantar Fasciitis

Interventions

DEVICE

ArthroCare TOPAZ™ MicroDebrider™ using Coblation

Percutaneous treatment of plantar fascia using the Topaz device. No incision performed.

PROCEDURE

Surgical Fasciotomy

Standard surgical fasciotomy using an incision to treat the plantar fascia.

Sponsors & Collaborators

  • ArthroCare Corporation

    lead OTHER

Principal Investigators

  • Lowell S. Weil, Sr., DPM · Weil Foot & Ankle Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
72 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00189592 on ClinicalTrials.gov